[1] 陆承平.兽医微生物学[M].5版.北京:中国农业出版社,2013. LU C P.Veterinary Microbiology[M].5th ed.Beijing:China Agriculture Press,2013.(in Chinese) [2] WILKIE I W,HARPER M,BOYCE J D,et al.Pasteurella multocida:Diseases and pathogenesis[J].Current Topics in Microbiology and Immunology,2012,361:1-22. [3] WILSON B A,HO M.Pasteurella multocida:From zoonosis to cellular microbiology[J].Clinical Microbiology Reviews,2013,26(3):631-655. [4] 赵梦坡,朱志森,黄育浩,等.多杀性巴氏杆菌疫苗研究进展[J].广东畜牧兽医科技,2022,47(6):45-51. ZHAO M P,ZHU Z S,HUANG Y H,et al.Research progress on Pasteurella multocida vaccine[J].Guangdong Journal of Animal and Veterinary Science,2022,47(6):45-51.(in Chinese) [5] 黄忍,张定练,肖驰.贵州部分地区规模猪场链球菌和多杀性巴氏杆菌的耐药性分析[J].饲料博览,2022,6:73-76. HUANG R,ZHANG D L,XIAO C.Drug resistance analysis of Streptococcus suis and Pasteurella multocida on large-scale pig farms in some areas of Guizhou province[J].Feed Review,2022,6:73-76.(in Chinese) [6] 邹本革,张伟,张瑞华,等.猪源多杀性巴氏杆菌的分离鉴定及耐药性分析[J].中国兽医杂志,2022,58(7):90-96. ZOU B G,ZHANG W,ZHANG R H,et al.Isolation,identification and drug resistance analysis of Pasteurella multocida from swine[J]. Chinese Journal of Veterinary Medicine,2022,58(7):90-96.(in Chinese) [7] 张亚楠,李亚菲,陈汝佳,等.A:L1 ST128型鸭源多杀性巴氏杆菌的耐药性及毒力分析[J].畜牧兽医学报,2021,52(10):2852-2863. ZHANG Y N,LI Y F,CHEN R J,et al.Resistance and virulence analysis of type A:L1 ST128Pasteurella multocida from ducks[J].Acta Veterinaria et Zootechnica Sinica,2021,52(10):2852-2863.(in Chinese) [8] 刘海燕,杨有文,王远微,等.6株山羊源多杀性巴氏杆菌血清型、耐药性及致病性分析[J].黑龙江畜牧兽医,2020,16:65-68. LIU H Y,YANG Y W,WANG Y W,et al.Serotype,drug resistance and pathogenicity of six Pasteurella multocida strains from goats[J].Heilongjiang Animal Science and Veterinary Medicine,2020,16:65-68.(in Chinese) [9] 陈杖榴,曾振灵.兽医药理学[M].4版.北京:中国农业出版社,2017. CHEN Z L,ZENG Z L.Veterinary Pharmacology[M].4th ed.Beijing:China Agriculture Press,2017.(in Chinese) [10] AYOUB M C.Polymyxins and bacterial membranes:A review of antibacterial activity and mechanisms of resistance[J].Membranes (Basel),2020,10(8):181. [11] 胡功政,崔小蝶,翟亚军,等.细菌黏菌素耐药性及其逆转机制研究进展[J].生物技术通报,2022,38(9):28-34. HU G Z,CUI X D,ZHAI Y J,et al.Research progress in colistin (COL) resistance in bacterial and its reversal mechanism[J].Biotechnology Bulletin,2022,38(9):28-34.(in Chinese) [12] 王莹,卢葛锦,景洁,等.畜禽源耐黏菌素大肠埃希氏菌的分离鉴定与特性分析[J].动物医学进展,2022,43(11):27-33. WANG Y,LU G J,JING J,et al.Isolation,identification and characterization of colistin resistant Escherichia coli from livestock and poultry[J].Progress in Veterinary Medicine,2022,43(11):27-33.(in Chinese) [13] LIU Y Y,WANG Y,WALSH T R,et al.Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China:A microbiological and molecular biological study[J].Lancet Infectious Diseases,2016,16(2):161-168. [14] KAPP T G,FOTTNER M,KESSLER H.Modification and functionalization of the guanidine group by tailor-made precursors[J].Jove-Journal of Visualized Experiments,2017,122:e54873. [15] SACZEWSKI F,BALEWSKI A.Biological activities of guanidine compounds,2008-2012 update[J].Expert Opinion on Therapeutic Patents,2013,23(8):965-995. [16] ZHANG X,HAN D,PEI P,et al.In vitro antibacterial activity of isopropoxy benzene guanidine against multidrug-resistant enterococci[J].Infection and Drug Resistance,2019,12:3943-3953. [17] ZHANG X,XIONG W,PENG X,et al.Isopropoxy benzene guanidine kills Staphylococcus aureus without detectable resistance[J].Frontiers in Microbiology,2021,12:633467. [18] LU Y,YANG L,ZHANG W,et al.Pharmacokinetics and pharmacodynamics of isopropoxy benzene guanidine against Clostridium perfringens in an intestinal infection model[J].Frontiers in Veterinary Science,2022,9:1004248. [19] HAN N,LI J,ZHAO F,et al.Isopropoxy benzene guanidine ameliorates Streptococcus suis infection in vivo and in vitro[J].International Journal of Molecular Science,2023,24(8):7354. [20] 张秀凤.异丙氧苯胍对金黄色葡萄球菌和大肠杆菌的抗菌作用及其机制研究[D].广州:华南农业大学,2020. ZHANG X F.Study on antibacterial effect and mechanism of isopropoxy benzene guanidine against Staphylococcus aureus and Escherichia coli[D].Guangzhou:South China Agricultural University,2020.(in Chinese) [21] KONG L,LU Y,YANG L,et al.Pharmacokinetics and pharmacodynamics of colistin combined with isopropoxy benzene guanidine against mcr-1-positive Salmonella in an intestinal infection model[J].Frontiers in Microbiology,2022,13:907116. [22] ODDS F C.Synergy,antagonism,and what the chequerboard puts between them[J].Journal of Antimicrobial Chemotherapy,2003,52(1):1. [23] 李静,杨靖亚,杨怡,等.联合用药:未来抗菌药物研发的趋势[J].中国抗生素杂志,2021,46(7):633-637. LI J,YANG J Y,YANG Y,et al.Drug combinations:The research trend of antibiotics in the future[J].Chinese Journal of Antibiotics,2021,46(7):633-637.(in Chinese) [24] 郭伟娜,赵霞,路振香.兔源多杀性巴氏杆菌的分离鉴定及耐药性分析[J].中国兽医杂志,2023,59(4):59-62. GUO W N,ZHAO X,LU Z X.Isolation,identification and drug resistance analysis of Pasteurella multocida from rabbits[J].Chinese Journal of Veterinary Medicine,2023,59(4):59-62.(in Chinese) [25] 王喜,元正菊,张信艳,等.鸡源多杀性巴氏杆菌的分离鉴定及生物学特性分析[J].中国兽医科学,2021,51(11):1411-1419. WANG X,YUAN Z J,ZHANG X Y,et al.Isolation,identification and biological characteristic analysis of Pasteurella multocida from chicken[J].Chinese Veterinary Science,2021,51(11):1411-1419.(in Chinese) [26] 毛畅思,党乔,魏星,等.牛多杀性巴氏杆菌的分离鉴定与药敏试验[J].动物医学进展,2021,42(1):46-50. MAO C S,DANG Q,WEI X,et al.Isolation,identification and drug sensitivity test of Pasteurella multocida in cattle[J].Progress in Veterinary Medicine,2021,42(1):46-50.(in Chinese) [27] 陈国权,张旭,阎朝华,等.鸭源多杀性巴氏杆菌的分离鉴定及耐药性分析[J].中国畜牧兽医, 2020,47(2):620-628. CHEN G Q,ZHANG X,YAN C H,et al.Isolation,identification and drug resistance analysis of Pasteurella multocida from ducks[J]. China Animal Husbandry&Veterinary Medicine,2020,47(2):620-628.(in Chinese) [28] 孙灵灵,袁宗辉,李梅,等.抗菌增效剂药动学与残留消除研究进展[J].中国畜牧兽医,2016,43(12):3141-3148. SUN L L,YUAN Z H,LI M,et al.Research progress on pharmacokinetics and residue elimination of antibacterial synergist[J].China Animal Husbandry&Veterinary Medicine,2016,43(12):3141-3148.(in Chinese) [29] GOMES A R,VARELA C L,PIRES A S,et al.Synthetic and natural guanidine derivatives as antitumor and antimicrobial agents:A review[J].Bioorganic Chemistry,2023,138:106600. [30] LIU Y,JIA Y,YANG K,et al.Metformin restores tetracyclines susceptibility against multidrug resistant bacteria[J].Advanced Science (Weinh),2020,7(12):1902227. [31] SAEED A,BOSCH A,BETTIOL M,et al.Novel guanidine compound against multidrug-resistant cystic fibrosis-associated bacterial species[J].Molecules,2018,23(5):1158. [32] LIU S,LIN L,YANG H,et al. Pasteurella multocida capsular:Lipopolysaccharide types D:L6 and A:L3 remain to be the main epidemic genotypes of pigs in China[J].Animal Diseases,2021,1(1):26. [33] SHARMA J,SHARMA D,SINGH A,et al.Colistin resistance and management of drug resistant infections[J].Canadian Journal of Infectious Diseases&Medical Microbiology,2022,2022:4315030. [34] DOMALAON R,DE SILVA P M,KUMAR A,et al.The anthelmintic drug niclosamide synergizes with colistin and reverses colistin resistance in Gram-negative bacilli[J].Antimicrobial Agents and Chemotherapy,2019,63(4):e02574-18. [35] HUANG Y,WANG Z,LIU Z,et al.Gigantol restores the sensitivity of mcr carrying multidrug-resistant bacteria to colistin[J].Phytomedicine,2023,117:154886. [36] ZHOU Y,LIU B,CHU X,et al.Commercialized artemisinin derivatives combined with colistin protect against critical Gram-negative bacterial infection[J].Communications Biology,2022,5(1):931. [37] GUO M,TIAN P,LI Q,et al.Gallium nitrate enhances antimicrobial activity of colistin against Klebsiella pneumoniae by inducing reactive oxygen species accumulation[J].Microbiology Spectrum,2023,11(4):e0033423. [38] LI J,ZHANG X,HAN N,et al.Mechanism of action of isopropoxy benzene guanidine against multidrug-resistant pathogens[J].Microbiology Spectrum,2022,11(1):e3422. [39] 李艳芹.黏菌素与加米霉素联用对多杀性巴氏杆菌的药动/药效学及作用机制研究[D].广州:华南农业大学,2020. LI Y Q.Study on pharmacokinetic/pharmacodynamic integration and action mechanism of colistin in combination with gamithromycin against Pasteurella multocida[D].Guangzhou:South China Agricultural University,2020.(in Chinese) |